(3R,4S,5S)-5-BENZYL-4-HYDROXY-3-[1(S)-(1,1-DIMETHYLETHOXYCARBONYLAMINO)-2-PHENYL-ETHYL]PYRROLIDIN-2-ONE

被引:0
作者
WEBER, HP [1 ]
ETTMAYER, P [1 ]
HUBNER, M [1 ]
GSTACH, H [1 ]
机构
[1] SANDOZ GMBH,FORSCHUNGSINST,A-1235 VIENNA,AUSTRIA
关键词
D O I
10.1107/S010827019500504X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The title compound, tert-butyl {1(S)-[(3R,4S,5S)-5-benzyl-4-hydroxy-2-oxo-3 -pyrrolidinyl]-2-phenylethyl}carbamate, C24H30N2O4, is an example of an all-cis trisubstituted pyrrolidin-2-one. The absolute configurations of the C atoms in the lactam ring were assigned to be 3R, 4S and 5S relative to the known chirality, 1S, of the C-alpha atom of the L-phenylalanine fragment in the compound. There is one intramolecular hydrogen bond between the pyrrolidin-2-one carbonyl O atom and the N-H group of the L-phenylalanine fragment [N-H ... O 2.936(5) Angstrom].
引用
收藏
页码:2139 / 2141
页数:3
相关论文
共 50 条
[31]   Concise and practical synthesis of (2S,3R,4R,5R) and (2S,3R,4R,5S)-1,6-dideoxy-1,6-iminosugars [J].
Tilekar, JN ;
Patil, NT ;
Jadhav, HS ;
Dhavale, DD .
TETRAHEDRON, 2003, 59 (11) :1873-1876
[32]   5-{(2S,3R,4S,5S,6R)-3,4-dihydroxy-6-hydroxymethyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydropyran-2-yloxy]tetrahydropyran-2-yloxy}-7-hydroxy-2-(4-hydroxyphenyl)chromen-4-one monohydrate [J].
Chen, Yuzhen ;
Wang, Airong ;
Gao, Haiyan ;
Niu, Shengyang .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 :O1901-U3554
[33]   Asymmetric syntheses of (1r,3R,4S)- and (1s,3R,4S)-(3,4-difluorocyclopentyl)-alanine derivatives [J].
Simpson, Robert D. ;
Zhao, Wei .
TETRAHEDRON-ASYMMETRY, 2009, 20 (13) :1515-1520
[34]   Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers [J].
Sapa, Jacek ;
Filipek, Barbara ;
Nowinski, Leszek .
PHARMACOLOGICAL REPORTS, 2011, 63 (02) :455-463
[35]   Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers [J].
Jacek Sapa ;
Barbara Filipek ;
Leszek Nowiński .
Pharmacological Reports, 2011, 63 :455-463
[36]   (1S, 2S)-2-[(3R, 4S)-3-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl]cyclohexanol [J].
Ben Ali, Karim ;
Chiaroni, Angele ;
Bohe, Luis .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 :O1719-O1720
[37]   (1R*,2S*,4S*,5S*)-Cyclohexane-1,2,4,5-tetrol [J].
Mehta, G ;
Sen, S ;
Dey, S .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 :O920-O922
[38]   (2R,3S,4S,5R)-4-hydroxy-3-iodo-5-methyltetrahydro-2-furylmethyl benzoate [J].
Bew, SP ;
Light, ME ;
Hursthouse, MB ;
Knight, DW ;
Middleton, RJ .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2001, 57 :O58-O60
[39]   Synthesis of 4-(R)-naphthalene-2-yloxy-1-(1-phenyl-(S)-ethyl)-pyrrolidin-3-(R)-ol and 4-(S)-naphthalen-2-yloxy-1-(1-phenyl-(S)-ethyl)-pyrrolidin-3-(S)-ol:: Versatile chiral intermediates for synthesis [J].
Holsworth, DD ;
Stier, M ;
Wei, W ;
Edmunds, JJ ;
Li, TS ;
Maiti, SN .
SYNTHETIC COMMUNICATIONS, 2004, 34 (23) :4421-4430
[40]   Short and efficient synthesis of (2S,3R,4R,5R) and (2S,3R,4R,5S)-tetrahydroxyazepanes via the Henry reaction [J].
Chakraborty, C ;
Dhavale, DD .
CARBOHYDRATE RESEARCH, 2006, 341 (07) :912-917